RPGK
CRSP icon

Retirement Planning Group (Kansas)’s CRISPR Therapeutics CRSP Stock Holding History

Retirement Planning Group (Kansas)’s Portfolio CRSP Stock Details CRSP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$203K Buy
+3,720
New +$196K 0.01% 527
2025
Q4 		– Sell
-3,720
Closed -$241K – 425
2025
Q3 		$241K Buy
+3,720
New +$214K 0.01% 362

Other funds holding CRSP

AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GP
GSK plc London $602M AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
SOCM
SR One Capital Management Wayne, Pennsylvania $1.04B AUM 262.99% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Retirement Planning Group (Kansas)'s CRSP Position: Q2 2026 in Review

Retirement Planning Group (Kansas) opened a new position in CRISPR Therapeutics (CRSP) in Q2 2026: 3,720 shares worth $203K. The stake represents 0.01% of the portfolio and ranks #527 among its holdings. This is a return to the name: Retirement Planning Group (Kansas) previously reported a position in CRSP as recently as Q3 2025.

Retirement Planning Group (Kansas) first reported a position in CRSP in Q3 2025 and has held it in 2 quarters since. The position peaked at $241K in Q3 2025. 524 funds tracked by Wall St. Rank hold CRSP as of Q2 2026.

  • Retirement Planning Group (Kansas) held 3,720 shares of CRISPR Therapeutics worth $203K as of Q2 2026.
  • CRISPR Therapeutics was a new Retirement Planning Group (Kansas) position in Q2 2026.
  • CRISPR Therapeutics made up 0.01% of Retirement Planning Group (Kansas)'s portfolio in Q2 2026, its #527 holding.
  • Retirement Planning Group (Kansas) first reported a position in CRISPR Therapeutics in Q3 2025 and has held it in 2 quarters since.
  • Retirement Planning Group (Kansas)'s CRISPR Therapeutics position peaked at $241K in Q3 2025.
  • 524 funds tracked by Wall St. Rank held CRISPR Therapeutics as of Q2 2026.

Based on Retirement Planning Group (Kansas)'s 13F filing for Q2 2026, filed 5 Aug 2026.